<?xml version="1.0" encoding="UTF-8"?>
<compound>
  <id type="integer">3006</id>
  <title>T3D2964</title>
  <common-name>Cerulenin</common-name>
  <description>Cerulenin is an antifungal antibiotic that inhibits sterol and fatty acid biosynthesis. In fatty acid synthesis, reported to bind in equimolar ratio to b-keto-acyl-ACP synthase. In sterol synthesis, inhibits HMG-CoA synthetase activity. It is also shown to inhibit feeding and induce dramatic weight loss in mice. It is found naturally in the Cephalosporium caerulensfungus. [Wikipedia]</description>
  <cas>17397-89-6</cas>
  <pubchem-id>5282054</pubchem-id>
  <chemical-formula>C12H17NO3</chemical-formula>
  <weight>223.120840</weight>
  <appearance>White powder.</appearance>
  <melting-point>93.5°C</melting-point>
  <boiling-point nil="true"/>
  <density nil="true"/>
  <solubility>Slightly soluble</solubility>
  <specific-gravity nil="true"/>
  <flash-point nil="true"/>
  <vapour-pressure nil="true"/>
  <route-of-exposure nil="true"/>
  <target nil="true"/>
  <mechanism-of-toxicity>Irreversibly binds to fatty acid synthase, specifically b-ketoacyl-acyl carrier protein synthase (FabH, FabB and FabF condensation enzymes). A number of tumor cells and cell lines have been observed to have highly upregulated expression and activity of fatty acid synthase (FAS). Inhibition of FAS by cerulenin leads to cytotoxicity and apoptosis in human cancer cell lines, an effect believed to be mediated by the accumulation of malonyl-coenzyme A in cells with an upregulated FAS pathway.</mechanism-of-toxicity>
  <metabolism></metabolism>
  <toxicity>LD50: 547 mg/kg (Oral, Mouse) (A308)</toxicity>
  <lethaldose nil="true"/>
  <carcinogenicity>No indication of carcinogenicity to humans (not listed by IARC).</carcinogenicity>
  <use-source>For use as a biochemical tool, Cerulenin is shown to cause dramatic weight loss in animals</use-source>
  <min-risk-level nil="true"/>
  <health-effects nil="true"/>
  <symptoms>Symptoms of overexposure include moderate to severe erythema (redness) and moderate edema (raised skin), nausea, vomiting, and headache.</symptoms>
  <treatment nil="true"/>
  <created-at type="dateTime">2009-07-21T20:28:13Z</created-at>
  <updated-at type="dateTime">2026-04-03T15:58:33Z</updated-at>
  <interacting-proteins nil="true"/>
  <wikipedia>Cerulenin</wikipedia>
  <uniprot-id></uniprot-id>
  <kegg-compound-id>C12058</kegg-compound-id>
  <omim-id></omim-id>
  <chebi-id>171741</chebi-id>
  <biocyc-id>CPD-6901</biocyc-id>
  <ctd-id nil="true"/>
  <stitch-id>Cerulenin</stitch-id>
  <drugbank-id>DB01034</drugbank-id>
  <pdb-id></pdb-id>
  <actor-id nil="true"/>
  <organism nil="true"/>
  <export type="boolean">true</export>
  <metabolizing-proteins nil="true"/>
  <transporting-proteins nil="true"/>
  <moldb-smiles>[H]\C(C)=C(\[H])C\C([H])=C(/[H])CCC(=O)[C@@]1([H])O[C@@]1([H])C(O)=N</moldb-smiles>
  <moldb-formula>C12H17NO3</moldb-formula>
  <moldb-inchi>InChI=1S/C12H17NO3/c1-2-3-4-5-6-7-8-9(14)10-11(16-10)12(13)15/h2-3,5-6,10-11H,4,7-8H2,1H3,(H2,13,15)/b3-2+,6-5+/t10-,11-/m1/s1</moldb-inchi>
  <moldb-inchikey>GVEZIHKRYBHEFX-NQQPLRFYSA-N</moldb-inchikey>
  <moldb-average-mass type="decimal">223.272</moldb-average-mass>
  <moldb-mono-mass type="decimal">223.120843411</moldb-mono-mass>
  <origin>Exogenous</origin>
  <state>Solid</state>
  <logp>1.2</logp>
  <hmdb-id>HMDB15168</hmdb-id>
  <chembl-id>CHEMBL45627</chembl-id>
  <chemspider-id>26530</chemspider-id>
  <structure-image-file-name nil="true"/>
  <structure-image-content-type nil="true"/>
  <structure-image-file-size type="integer" nil="true"/>
  <structure-image-updated-at type="dateTime" nil="true"/>
  <biodb-id nil="true"/>
  <synthesis-reference>&lt;p&gt;Garfield P. Royer, Craig A. Townsend, &amp;#8220;Cerulenin compounds for fatty acid synthesis inhibition.&amp;#8221; U.S. Patent US5539132, issued July, 1975.&lt;/p&gt;</synthesis-reference>
  <structure-image-caption nil="true"/>
  <chemdb-id>CHEM002327</chemdb-id>
  <dsstox-id>DTXSID2040995</dsstox-id>
  <toxcast-id nil="true"/>
  <stoff-ident-origin nil="true"/>
  <stoff-ident-id nil="true"/>
  <susdat-id>NS00025714</susdat-id>
  <iupac>(2R,3S)-3-[(4E,7E)-nona-4,7-dienoyl]oxirane-2-carboximidic acid</iupac>
</compound>
